Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS2W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -0.8 %
2W -2.0 %
1M 0.3 %
3M 3.3 %
6M 13.5 %
9M 13.5 %
1Y -25.0 %
Alpha
-31.6%
Beta
0.39
sharpe-R
-0.47
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:07
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -49.92%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-17 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Buy All -7.44%
RGNX Sell All -9.54%
Assets Rebalanced
None
2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.06% -9.29%
CARA Cara Therapeutics, Inc. Sell -5.35% -15.7%
The percentage of cash held in the portfolio is: 98.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -7.3%
SGMO Sell All -4.88%
NTRA Sell All -3.14%
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.45% -8.76%
SGMO Sangamo Therapeutics, Inc. Buy 7.5% -8.13%
NTRA Natera, Inc. Buy 7.97% -2.45%
RGNX REGENXBIO Inc. Buy 6.95% -10.78%
CARA Cara Therapeutics, Inc. Sell -5.02% -8.47%
The percentage of cash held in the portfolio is: 75.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
UTMD Buy All 1.26%
AADI Buy All 7.27%
RCKT Buy All 5.28%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.48% -7.3%
SGMO Sangamo Therapeutics, Inc. Buy 7.54% -6.5%
NTRA Natera, Inc. Buy 7.91% -1.96%
RGNX REGENXBIO Inc. Buy 7.83% 1.73%
UTMD Utah Medical Products, Inc. Sell -3.83% 2.37%
AADI Aadi Bioscience, Inc. Sell -3.76% 4.15%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.9% 0.67%
CARA Cara Therapeutics, Inc. Sell -4.72% -3.31%
The percentage of cash held in the portfolio is: 85.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -7.77%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 7.32% -7.46%
FATE Fate Therapeutics, Inc. Buy 8.11% 2.19%
SGMO Sangamo Therapeutics, Inc. Buy 8.2% 3.25%
NTRA Natera, Inc. Buy 7.89% -0.64%
RGNX REGENXBIO Inc. Buy 7.91% 4.46%
UTMD Utah Medical Products, Inc. Sell -3.77% 2.3%
AADI Aadi Bioscience, Inc. Sell -3.78% 2.08%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.95% -2.31%
CARA Cara Therapeutics, Inc. Sell -4.76% -5.79%
The percentage of cash held in the portfolio is: 76.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Buy All 7.62%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 7.46% -5.58%
FATE Fate Therapeutics, Inc. Buy 8.23% 3.65%
SGMO Sangamo Therapeutics, Inc. Buy 8.13% 2.44%
NTRA Natera, Inc. Buy 7.97% 0.41%
RGNX REGENXBIO Inc. Buy 7.91% 4.46%
HROW Harrow Health, Inc. Sell -3.67% 8.07%
UTMD Utah Medical Products, Inc. Sell -3.78% 2.14%
AADI Aadi Bioscience, Inc. Sell -3.87% -0.35%
RCKT Rocket Pharmaceuticals, Inc. Sell -4.17% -7.97%
CARA Cara Therapeutics, Inc. Sell -4.68% -4.13%
The percentage of cash held in the portfolio is: 80.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -0.6%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 7.37% -6.96%
FATE Fate Therapeutics, Inc. Buy 7.61% -4.38%
SGMO Sangamo Therapeutics, Inc. Buy 8.02% 0.81%
NTRA Natera, Inc. Buy 7.86% -1.15%
RGNX REGENXBIO Inc. Buy 7.93% 4.46%
FGEN FibroGen, Inc. Sell -3.52% 8.1%
HROW Harrow Health, Inc. Sell -3.68% 8.24%
UTMD Utah Medical Products, Inc. Sell -3.79% 2.17%
AADI Aadi Bioscience, Inc. Sell -3.66% 5.54%
RCKT Rocket Pharmaceuticals, Inc. Sell -4.12% -6.44%
CARA Cara Therapeutics, Inc. Sell -4.57% -1.45%
The percentage of cash held in the portfolio is: 84.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Buy All -1.95%
MDRX Buy All 47.11%
BHVN Sell All 0.72%
AGEN Sell All -8.62%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 5.52% -3.38%
AGEN Agenus Inc. Buy 5.24% -8.36%
BLFS BioLife Solutions, Inc. Buy 7.54% -5.94%
FATE Fate Therapeutics, Inc. Buy 7.46% -7.3%
SGMO Sangamo Therapeutics, Inc. Buy 7.65% -4.88%
NTRA Natera, Inc. Buy 8.06% 0.16%
RGNX REGENXBIO Inc. Buy 7.44% -3.1%
TNDM Tandem Diabetes Care, Inc. Sell -4.03% -3.12%
MDRX Allscripts Healthcare Solutions, Inc. Sell -2.17% 44.44%
FGEN FibroGen, Inc. Sell -3.66% 5.56%
HROW Harrow Health, Inc. Sell -3.6% 11.22%
UTMD Utah Medical Products, Inc. Sell -3.83% 2.27%
AADI Aadi Bioscience, Inc. Sell -3.71% 5.19%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.97% -1.44%
CARA Cara Therapeutics, Inc. Sell -4.5% 1.24%
The percentage of cash held in the portfolio is: 80.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 5.54% -2%
AGEN Agenus Inc. Buy 5.61% -0.78%
SIGA SIGA Technologies, Inc. Buy 9.71% -6.42%
BLFS BioLife Solutions, Inc. Buy 7.66% -3.5%
FATE Fate Therapeutics, Inc. Buy 7.56% -5.11%
SGMO Sangamo Therapeutics, Inc. Buy 7.96% 0%
NTRA Natera, Inc. Buy 7.99% 0.37%
RGNX REGENXBIO Inc. Buy 7.6% 0%
TNDM Tandem Diabetes Care, Inc. Sell -4.06% -4.99%
MDRX Allscripts Healthcare Solutions, Inc. Sell -2.35% 39.33%
FGEN FibroGen, Inc. Sell -3.69% 3.97%
HROW Harrow Health, Inc. Sell -3.67% 8.57%
UTMD Utah Medical Products, Inc. Sell -3.87% 0.13%
AADI Aadi Bioscience, Inc. Sell -3.86% 0.35%
RCKT Rocket Pharmaceuticals, Inc. Sell -4% -3.17%
CARA Cara Therapeutics, Inc. Sell -4.51% 0%
The percentage of cash held in the portfolio is: 70.37%
New Assets Added
  • CARA
  • RGNX
Assets Removed
Asset Action Perf %
CPRX Sell All -5.84%
TGTX Sell All -0.69%
SENS Sell All -14.96%
Assets Rebalanced
None
2025-01-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 5.65% -0.08%
AGEN Agenus Inc. Buy 5.23% -7.57%
SIGA SIGA Technologies, Inc. Buy 9.99% -3.6%
SENS Senseonics Holdings, Inc. Buy 3.29% -3.54%
TGTX TG Therapeutics, Inc. Buy 5.61% 4.51%
BLFS BioLife Solutions, Inc. Buy 7.76% -2.12%
CPRX Catalyst Pharmaceuticals, Inc. Buy 7.68% -3.21%
FATE Fate Therapeutics, Inc. Buy 7.96% 0%
SGMO Sangamo Therapeutics, Inc. Buy 7.96% 0%
NTRA Natera, Inc. Buy 7.96% 0%
TNDM Tandem Diabetes Care, Inc. Sell -4.05% -4.84%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.43% 11.11%
FGEN FibroGen, Inc. Sell -3.83% 0.28%
HROW Harrow Health, Inc. Sell -3.78% 5.68%
UTMD Utah Medical Products, Inc. Sell -3.87% 0.15%
AADI Aadi Bioscience, Inc. Sell -3.86% 0.35%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.98% -2.69%
The percentage of cash held in the portfolio is: 57.72%
New Assets Added
  • FATE
  • SGMO
  • NTRA
Assets Removed
Asset Action Perf %
ORGO Sell All 13.21%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 8.2% 14.11%
BHVN Biohaven Ltd. Buy 5.42% -3.33%
AGEN Agenus Inc. Buy 5.28% -5.74%
SIGA SIGA Technologies, Inc. Buy 10.07% -2.03%
SENS Senseonics Holdings, Inc. Buy 3.11% -7.96%
TGTX TG Therapeutics, Inc. Buy 5.56% 4.54%
BLFS BioLife Solutions, Inc. Buy 7.86% 0%
CPRX Catalyst Pharmaceuticals, Inc. Buy 7.86% 0%
TNDM Tandem Diabetes Care, Inc. Sell -3.95% -3%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.24% 15.44%
FGEN FibroGen, Inc. Sell -3.62% 4.76%
HROW Harrow Health, Inc. Sell -3.83% 3.72%
UTMD Utah Medical Products, Inc. Sell -3.84% 0%
AADI Aadi Bioscience, Inc. Sell -3.84% 0%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.84% 0%
The percentage of cash held in the portfolio is: 72.78%
New Assets Added
  • UTMD
  • AADI
  • RCKT
  • BLFS
  • CPRX
Assets Removed
Asset Action Perf %
MDXG Sell All 2.61%
CERS Sell All 4.86%
ATXS Sell All -4.24%
NVRO Sell All 19.34%
AXSM Sell All 12.15%
DNLI Sell All 8.88%
MD Sell All 1.36%
LGND Sell All 7.83%
Assets Rebalanced
None
2025-01-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Buy 7.69% 2.72%
CERS Cerus Corporation Buy 8.58% 14.59%
ATXS Astria Therapeutics, Inc. Buy 7.2% -3.85%
NVRO Nevro Corp. Buy 7.12% 17.69%
AXSM Axsome Therapeutics, Inc. Buy 7% 9.29%
DNLI Denali Therapeutics Inc. Buy 7.04% 9.3%
MD Pediatrix Medical Group, Inc. Buy 7.85% 3.29%
LGND Ligand Pharmaceuticals Incorporated Buy 7.44% 7.1%
ORGO Organogenesis Holdings Inc. Buy 7.69% 6.91%
BHVN Biohaven Ltd. Buy 5.52% -1.69%
AGEN Agenus Inc. Buy 5.21% -7.05%
SIGA SIGA Technologies, Inc. Buy 9.98% -2.97%
SENS Senseonics Holdings, Inc. Buy 3.33% -1.77%
TGTX TG Therapeutics, Inc. Buy 5.58% 4.79%
TNDM Tandem Diabetes Care, Inc. Sell -3.95% -3.12%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.41% 11.11%
FGEN FibroGen, Inc. Sell -3.7% 2.78%
HROW Harrow Health, Inc. Sell -3.87% 2.68%
The percentage of cash held in the portfolio is: 17.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
GERN Buy All -2.04%
NUTX Sell All 33.72%
ACRS Sell All -4.4%
Assets Rebalanced
None
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 7.39% 26.44%
ACRS Aclaris Therapeutics, Inc. Buy 6.56% -2%
MDXG MiMedx Group, Inc. Buy 7.36% -1.25%
CERS Cerus Corporation Buy 8.66% 16.22%
ATXS Astria Therapeutics, Inc. Buy 7.21% -3.21%
NVRO Nevro Corp. Buy 7.11% 18.16%
AXSM Axsome Therapeutics, Inc. Buy 6.99% 9.54%
DNLI Denali Therapeutics Inc. Buy 6.92% 7.86%
MD Pediatrix Medical Group, Inc. Buy 7.94% 4.86%
LGND Ligand Pharmaceuticals Incorporated Buy 7.36% 6.35%
ORGO Organogenesis Holdings Inc. Buy 8.05% 12.31%
BHVN Biohaven Ltd. Buy 5.72% 2.31%
AGEN Agenus Inc. Buy 5.25% -6.01%
SIGA SIGA Technologies, Inc. Buy 10.16% -0.78%
SENS Senseonics Holdings, Inc. Buy 3.16% -6.19%
TGTX TG Therapeutics, Inc. Buy 5.3% 0%
GERN Geron Corporation Sell -3.82% -0.68%
TNDM Tandem Diabetes Care, Inc. Sell -3.96% -3.6%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.19% 16.33%
FGEN FibroGen, Inc. Sell -3.67% 3.17%
HROW Harrow Health, Inc. Sell -3.81% 3.9%
The percentage of cash held in the portfolio is: 7.3%
New Assets Added
  • TGTX
Assets Removed
Asset Action Perf %
AVXL Buy All 6.92%
INSM Sell All 12.62%
AXGN Sell All -1.75%
Assets Rebalanced
None
2025-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 7.92% 13.85%
AXGN AxoGen, Inc. Buy 6.77% -0.6%
NUTX Nutex Health Inc. Buy 7.87% 32.94%
ACRS Aclaris Therapeutics, Inc. Buy 6.81% 0.4%
MDXG MiMedx Group, Inc. Buy 7.53% -0.34%
CERS Cerus Corporation Buy 8.04% 6.49%
ATXS Astria Therapeutics, Inc. Buy 7.18% -4.88%
NVRO Nevro Corp. Buy 7.42% 21.7%
AXSM Axsome Therapeutics, Inc. Buy 7.11% 9.98%
DNLI Denali Therapeutics Inc. Buy 6.72% 3.35%
MD Pediatrix Medical Group, Inc. Buy 7.85% 2.29%
LGND Ligand Pharmaceuticals Incorporated Buy 7.31% 4.31%
ORGO Organogenesis Holdings Inc. Buy 7.76% 6.91%
BHVN Biohaven Ltd. Buy 5.7% 0.77%
AGEN Agenus Inc. Buy 5.28% -6.79%
SIGA SIGA Technologies, Inc. Buy 10.48% 0.94%
SENS Senseonics Holdings, Inc. Buy 3.42% 0%
AVXL Anavex Life Sciences Corp. Sell -4.01% 0.57%
GERN Geron Corporation Sell -3.93% -2.38%
TNDM Tandem Diabetes Care, Inc. Sell -4% -3.4%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.35% 13.33%
FGEN FibroGen, Inc. Sell -3.88% -0.99%
HROW Harrow Health, Inc. Sell -3.99% 0.68%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SENS
Assets Removed
Asset Action Perf %
VKTX Buy All 12.24%
ESPR Sell All -10.26%
Assets Rebalanced
None
2025-01-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 6.31% -11.11%
INSM Insmed Incorporated Buy 7.81% 12.93%
AXGN AxoGen, Inc. Buy 6.94% 2.47%
NUTX Nutex Health Inc. Buy 7.53% 28%
ACRS Aclaris Therapeutics, Inc. Buy 6.87% 2%
MDXG MiMedx Group, Inc. Buy 7.69% 2.38%
CERS Cerus Corporation Buy 7.51% 0%
ATXS Astria Therapeutics, Inc. Buy 7.28% -3.08%
NVRO Nevro Corp. Buy 7.27% 19.81%
AXSM Axsome Therapeutics, Inc. Buy 7.12% 10.82%
DNLI Denali Therapeutics Inc. Buy 7% 8.28%
MD Pediatrix Medical Group, Inc. Buy 7.71% 1.14%
LGND Ligand Pharmaceuticals Incorporated Buy 7.29% 4.62%
ORGO Organogenesis Holdings Inc. Buy 7.65% 6.01%
BHVN Biohaven Ltd. Buy 5.87% 4.3%
AGEN Agenus Inc. Buy 5.53% -1.83%
SIGA SIGA Technologies, Inc. Buy 10.45% 1.25%
VKTX Viking Therapeutics, Inc. Sell -3.21% 11.12%
AVXL Anavex Life Sciences Corp. Sell -3.88% 3.32%
GERN Geron Corporation Sell -3.92% -2.72%
TNDM Tandem Diabetes Care, Inc. Sell -3.87% -0.54%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.31% 13.89%
FGEN FibroGen, Inc. Sell -3.83% -0.4%
HROW Harrow Health, Inc. Sell -3.99% 0%
The percentage of cash held in the portfolio is: 2.18%
New Assets Added
  • HROW
Assets Removed
None
Assets Rebalanced
Asset Action Weight
INSM Buy 0.34%
ORGO Buy 0.41%
MD Buy 0.8%
LGND Buy 0.96%
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 6.74% -5.98%
AXGN AxoGen, Inc. Buy 7.08% 3.51%
INSM Insmed Incorporated Buy 7.08% 13.81%
ACRS Aclaris Therapeutics, Inc. Buy 7.08% 4%
NUTX Nutex Health Inc. Buy 7.08% 19.09%
MDXG MiMedx Group, Inc. Buy 7.73% 1.93%
CERS Cerus Corporation Buy 7.42% -2.16%
ATXS Astria Therapeutics, Inc. Buy 7.3% -3.72%
MD Pediatrix Medical Group, Inc. Buy 6.51% 0.5%
DNLI Denali Therapeutics Inc. Buy 7.08% 8.42%
AXSM Axsome Therapeutics, Inc. Buy 7.08% 9.09%
LGND Ligand Pharmaceuticals Incorporated Buy 6.43% 5.06%
NVRO Nevro Corp. Buy 7.08% 15.57%
ORGO Organogenesis Holdings Inc. Buy 6.89% 5.11%
AGEN Agenus Inc. Buy 5.43% -4.44%
BHVN Biohaven Ltd. Buy 5.9% 3.92%
SIGA SIGA Technologies, Inc. Buy 10.42% 0%
VKTX Viking Therapeutics, Inc. Sell -3.15% 13.38%
AVXL Anavex Life Sciences Corp. Sell -3.84% 5.31%
GERN Geron Corporation Sell -3.92% -1.7%
TNDM Tandem Diabetes Care, Inc. Sell -3.85% 0.85%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.68% 5.33%
FGEN FibroGen, Inc. Sell -3.86% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • FGEN
  • SIGA
Assets Removed
Asset Action Perf %
ORMP Buy All 2.94%
EBS Buy All -15.52%
MCRB Buy All -24.76%
AORT Sell All 1.82%
Assets Rebalanced
Asset Action Weight
MD Sell -1.1%
LGND Sell -1.54%
AXGN Sell -1.1%
DNLI Sell -1.14%
ACRS Sell -1.15%
AXSM Sell -1.19%
NVRO Sell -1.68%
INSM Sell -1.92%
NUTX Sell -2.35%
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 6.49% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 6.54% -8.12%
AXGN AxoGen, Inc. Buy 8.15% 3.95%
INSM Insmed Incorporated Buy 8.74% 11.34%
NUTX Nutex Health Inc. Buy 9.45% 20.31%
ACRS Aclaris Therapeutics, Inc. Buy 8.17% 4%
MD Pediatrix Medical Group, Inc. Buy 7.53% 0%
MDXG MiMedx Group, Inc. Buy 7.8% 3.63%
NVRO Nevro Corp. Buy 8.31% 10.38%
LGND Ligand Pharmaceuticals Incorporated Buy 8.01% 6.42%
AXSM Axsome Therapeutics, Inc. Buy 7.72% 2.59%
CERS Cerus Corporation Buy 7.53% 0%
DNLI Denali Therapeutics Inc. Buy 8.07% 7.16%
ATXS Astria Therapeutics, Inc. Buy 7.31% -2.82%
ORGO Organogenesis Holdings Inc. Buy 6.9% 6.01%
AGEN Agenus Inc. Buy 5.64% 0%
BHVN Biohaven Ltd. Buy 5.64% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.43% 3.36%
VKTX Viking Therapeutics, Inc. Sell -3.02% 16.38%
AVXL Anavex Life Sciences Corp. Sell -3.76% 6.64%
EBS Emergent BioSolutions Inc. Sell -4.37% -8.61%
GERN Geron Corporation Sell -3.85% -0.68%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.86% 0%
TNDM Tandem Diabetes Care, Inc. Sell -3.86% 0%
MCRB Seres Therapeutics, Inc. Sell -3.86% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • TNDM
  • MCRB
  • AGEN
  • BHVN
Assets Removed
Asset Action Perf %
FATE Buy All 24.57%
APLS Buy All -9.8%
Assets Rebalanced
None
2025-01-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 6.48% 1.62%
ESPR Esperion Therapeutics, Inc. Buy 6.9% -5.56%
AXGN AxoGen, Inc. Buy 7.98% -0.88%
INSM Insmed Incorporated Buy 8.47% 5.19%
NUTX Nutex Health Inc. Buy 9.52% 18.16%
ACRS Aclaris Therapeutics, Inc. Buy 8.29% 2.8%
MD Pediatrix Medical Group, Inc. Buy 7.64% -1.14%
MDXG MiMedx Group, Inc. Buy 7.99% 3.4%
NVRO Nevro Corp. Buy 8.32% 7.78%
LGND Ligand Pharmaceuticals Incorporated Buy 7.84% 1.46%
AXSM Axsome Therapeutics, Inc. Buy 7.57% -1.94%
CERS Cerus Corporation Buy 7.47% -3.24%
DNLI Denali Therapeutics Inc. Buy 7.88% 2%
ATXS Astria Therapeutics, Inc. Buy 7.44% -3.72%
ORGO Organogenesis Holdings Inc. Buy 6.7% 0.3%
FATE Fate Therapeutics, Inc. Sell -2.65% 27.43%
ORMP Oramed Pharmaceuticals Inc. Sell -3.49% 4.2%
APLS Apellis Pharmaceuticals, Inc. Sell -4.05% -9.09%
VKTX Viking Therapeutics, Inc. Sell -3.08% 16.94%
AVXL Anavex Life Sciences Corp. Sell -3.6% 12.7%
EBS Emergent BioSolutions Inc. Sell -4.33% -4.99%
GERN Geron Corporation Sell -3.86% 1.7%
The percentage of cash held in the portfolio is: 8.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
TGTX Buy All NA
TNDM Sell All NA
BLUE Sell All NA
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.88% 0.47%
BLUE bluebird bio, Inc. Buy 4.87% -16.73%
AORT Artivion, Inc. Buy 6.56% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 7.03% -3.42%
AXGN AxoGen, Inc. Buy 8.1% 0.99%
INSM Insmed Incorporated Buy 8.47% 5.54%
NUTX Nutex Health Inc. Buy 9.5% 18.31%
ACRS Aclaris Therapeutics, Inc. Buy 8.07% 0.4%
MD Pediatrix Medical Group, Inc. Buy 7.57% -1.64%
MDXG MiMedx Group, Inc. Buy 7.92% 2.95%
NVRO Nevro Corp. Buy 8.17% 6.13%
LGND Ligand Pharmaceuticals Incorporated Buy 7.75% 0.73%
AXSM Axsome Therapeutics, Inc. Buy 7.69% -0.06%
CERS Cerus Corporation Buy 7.57% -1.62%
DNLI Denali Therapeutics Inc. Buy 7.76% 0.79%
ATXS Astria Therapeutics, Inc. Buy 7.66% -0.51%
ORGO Organogenesis Holdings Inc. Buy 6.66% 0%
TGTX TG Therapeutics, Inc. Sell -3.81% -4.07%
FATE Fate Therapeutics, Inc. Sell -2.6% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.54% 2.52%
APLS Apellis Pharmaceuticals, Inc. Sell -4% -8.35%
VKTX Viking Therapeutics, Inc. Sell -3.06% 17.17%
AVXL Anavex Life Sciences Corp. Sell -3.96% 3.79%
EBS Emergent BioSolutions Inc. Sell -4.36% -5.95%
GERN Geron Corporation Sell -3.89% 0.68%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ORGO
Assets Removed
Asset Action Perf %
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.82% -3.76%
BLUE bluebird bio, Inc. Buy 5.05% -16.43%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.02% -4.51%
AORT Artivion, Inc. Buy 6.53% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 7.11% -5.56%
AXGN AxoGen, Inc. Buy 8.51% 2.63%
INSM Insmed Incorporated Buy 8.45% 1.84%
NUTX Nutex Health Inc. Buy 8.49% 2.16%
ACRS Aclaris Therapeutics, Inc. Buy 8.34% 0.4%
MD Pediatrix Medical Group, Inc. Buy 7.96% 0%
MDXG MiMedx Group, Inc. Buy 7.96% 0%
NVRO Nevro Corp. Buy 7.96% 0%
LGND Ligand Pharmaceuticals Incorporated Buy 7.96% 0%
AXSM Axsome Therapeutics, Inc. Buy 7.96% 0%
CERS Cerus Corporation Buy 7.96% 0%
DNLI Denali Therapeutics Inc. Buy 7.96% 0%
ATXS Astria Therapeutics, Inc. Buy 7.96% 0%
TGTX TG Therapeutics, Inc. Sell -4.08% -7.79%
FATE Fate Therapeutics, Inc. Sell -2.84% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.69% 1.68%
APLS Apellis Pharmaceuticals, Inc. Sell -4.04% -5.79%
VKTX Viking Therapeutics, Inc. Sell -3.39% 11.32%
AVXL Anavex Life Sciences Corp. Sell -4.57% -7.39%
EBS Emergent BioSolutions Inc. Sell -4.3% -1.17%
GERN Geron Corporation Sell -4.14% -2.38%
The percentage of cash held in the portfolio is: 3.07%
New Assets Added
  • MD
  • MDXG
  • NVRO
  • LGND
  • AXSM
  • CERS
  • DNLI
  • ATXS
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.78% -4.19%
BLUE bluebird bio, Inc. Buy 4.87% -19.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 5.86% -6.67%
AORT Artivion, Inc. Buy 6.43% -1.82%
ARDX Ardelyx, Inc. Buy 6.89% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 7.18% -4.27%
AXGN AxoGen, Inc. Buy 8.27% -0.05%
INSM Insmed Incorporated Buy 8.19% -0.93%
NUTX Nutex Health Inc. Buy 8.28% 0%
ACRS Aclaris Therapeutics, Inc. Buy 8.28% 0%
TGTX TG Therapeutics, Inc. Sell -4.01% -6.21%
FATE Fate Therapeutics, Inc. Sell -2.68% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.71% 0.84%
APLS Apellis Pharmaceuticals, Inc. Sell -3.84% -0.91%
VKTX Viking Therapeutics, Inc. Sell -3.29% 13.69%
AVXL Anavex Life Sciences Corp. Sell -4.21% 0.76%
EBS Emergent BioSolutions Inc. Sell -4.22% 0.53%
GERN Geron Corporation Sell -4.03% 0%
The percentage of cash held in the portfolio is: 59.97%
New Assets Added
  • GERN
  • NUTX
  • ACRS
Assets Removed
Asset Action Perf %
NUTX Buy All -3.63%
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.8% -3.07%
BLUE bluebird bio, Inc. Buy 5.12% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.07% -2.56%
AORT Artivion, Inc. Buy 6.31% -2.94%
ARDX Ardelyx, Inc. Buy 7.16% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 7.25% -2.56%
AXGN AxoGen, Inc. Buy 8.21% 0%
INSM Insmed Incorporated Buy 8.21% 0%
TGTX TG Therapeutics, Inc. Sell -3.71% 1.18%
FATE Fate Therapeutics, Inc. Sell -2.75% 26.29%
ORMP Oramed Pharmaceuticals Inc. Sell -3.69% 0.84%
NUTX Nutex Health Inc. Sell -3.77% 0.39%
APLS Apellis Pharmaceuticals, Inc. Sell -3.94% -4.19%
VKTX Viking Therapeutics, Inc. Sell -3.74% 1.09%
AVXL Anavex Life Sciences Corp. Sell -4.21% 0%
EBS Emergent BioSolutions Inc. Sell -4.21% 0%
The percentage of cash held in the portfolio is: 75.87%
New Assets Added
  • AVXL
  • EBS
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.84% -3.63%
BLUE bluebird bio, Inc. Buy 5.17% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.15% -2.46%
AORT Artivion, Inc. Buy 6.5% -1.16%
ARDX Ardelyx, Inc. Buy 6.25% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 7.54% 0%
TGTX TG Therapeutics, Inc. Sell -3.91% -3.14%
FATE Fate Therapeutics, Inc. Sell -3.17% 16%
ORMP Oramed Pharmaceuticals Inc. Sell -3.78% -0.42%
NUTX Nutex Health Inc. Sell -3.83% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -3.83% 0%
VKTX Viking Therapeutics, Inc. Sell -3.83% 0%
The percentage of cash held in the portfolio is: 84.9%
New Assets Added
  • NUTX
  • APLS
  • VKTX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 6.06% 0.36%
BLUE bluebird bio, Inc. Buy 5.15% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.14% -2.46%
AORT Artivion, Inc. Buy 6.56% 0%
ARDX Ardelyx, Inc. Buy 6.56% 0%
TGTX TG Therapeutics, Inc. Sell -3.89% -2.75%
FATE Fate Therapeutics, Inc. Sell -3.59% 4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 80.75%
New Assets Added
  • ORMP
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.97% -0.82%
BLUE bluebird bio, Inc. Buy 5.47% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.27% 0%
TGTX TG Therapeutics, Inc. Sell -3.77% 0%
FATE Fate Therapeutics, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 89.8%
New Assets Added
  • FATE
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.99% 0%
BLUE bluebird bio, Inc. Buy 5.99% 0%
TGTX TG Therapeutics, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 91.78%
New Assets Added
  • TGTX
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-12-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Buy All 4.38%
PCRX Sell All 0.52%
Assets Rebalanced
None
2024-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.09% 3.88%
CARA Cara Therapeutics, Inc. Sell -2.99% 8.76%
The percentage of cash held in the portfolio is: 94.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All 14.63%
ATEC Buy All 4.8%
NKTR Buy All 4.67%
Assets Rebalanced
None
2024-12-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.11% 4.09%
CUTR Cutera, Inc. Sell -3.41% 14.63%
ATEC Alphatec Holdings, Inc. Sell -3.79% 5.3%
NKTR Nektar Therapeutics Sell -3.74% 6.54%
CARA Cara Therapeutics, Inc. Sell -3.08% 5.84%
The percentage of cash held in the portfolio is: 105.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 32.43%
Assets Rebalanced
None
2024-12-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.11% 4.03%
FATE Fate Therapeutics, Inc. Sell -2.28% 38.18%
CUTR Cutera, Inc. Sell -3.51% 12.2%
ATEC Alphatec Holdings, Inc. Sell -3.85% 3.8%
NKTR Nektar Therapeutics Sell -3.78% 5.61%
CARA Cara Therapeutics, Inc. Sell -3.13% 4.38%
The percentage of cash held in the portfolio is: 108.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Buy All 43.06%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.35% 6.5%
IBRX ImmunityBio, Inc. Sell -2.31% 37.5%
FATE Fate Therapeutics, Inc. Sell -2.74% 26.35%
CUTR Cutera, Inc. Sell -3.53% 12.2%
ATEC Alphatec Holdings, Inc. Sell -3.9% 3.1%
NKTR Nektar Therapeutics Sell -3.83% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.21% 2.55%
The percentage of cash held in the portfolio is: 111.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
SEM Buy All 3.29%
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 6.77% -1.94%
PCRX Pacira BioSciences, Inc. Buy 8.2% 3.51%
SEM Select Medical Holdings Corporation Sell -3.77% 2.16%
IBRX ImmunityBio, Inc. Sell -3.45% 7.94%
FATE Fate Therapeutics, Inc. Sell -2.89% 22.97%
CUTR Cutera, Inc. Sell -3.87% 4.88%
ATEC Alphatec Holdings, Inc. Sell -3.92% 3.5%
NKTR Nektar Therapeutics Sell -3.88% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.31% 0.36%
The percentage of cash held in the portfolio is: 110.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 6.16%
MGNX Sell All -1.76%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.25% 7.32%
MGNX MacroGenics, Inc. Buy 5.96% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 8.43% 23.55%
PCRX Pacira BioSciences, Inc. Buy 7.84% 0%
SEM Select Medical Holdings Corporation Sell -3.76% 1.43%
IBRX ImmunityBio, Inc. Sell -3.53% 4.76%
FATE Fate Therapeutics, Inc. Sell -3.41% 8.11%
CUTR Cutera, Inc. Sell -3.63% 9.76%
ATEC Alphatec Holdings, Inc. Sell -3.86% 3.9%
NKTR Nektar Therapeutics Sell -3.8% 5.61%
CARA Cara Therapeutics, Inc. Sell -3.51% -6.57%
The percentage of cash held in the portfolio is: 97.02%
New Assets Added
None
Assets Removed
Asset Action Perf %
PACB Buy All -23.86%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6% 4.6%
MGNX MacroGenics, Inc. Buy 5.89% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 7.95% 18.06%
RVNC Revance Therapeutics, Inc. Buy 7.73% 0%
PCRX Pacira BioSciences, Inc. Buy 7.73% 0%
SEM Select Medical Holdings Corporation Sell -3.79% -0.84%
PACB Pacific Biosciences of California, Inc. Sell -4.44% -18.18%
IBRX ImmunityBio, Inc. Sell -3.43% 5.95%
FATE Fate Therapeutics, Inc. Sell -3.17% 13.51%
CUTR Cutera, Inc. Sell -4.16% -4.88%
ATEC Alphatec Holdings, Inc. Sell -3.99% -0.5%
NKTR Nektar Therapeutics Sell -3.78% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.24% 0%
The percentage of cash held in the portfolio is: 94.71%
New Assets Added
  • CARA
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.06% 6.13%
MGNX MacroGenics, Inc. Buy 5.78% 1.18%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.19% -0.31%
ESPR Esperion Therapeutics, Inc. Buy 7.03% 4.84%
SEM Select Medical Holdings Corporation Sell -3.78% -1.08%
PACB Pacific Biosciences of California, Inc. Sell -3.89% -3.98%
IBRX ImmunityBio, Inc. Sell -3.29% 9.52%
FATE Fate Therapeutics, Inc. Sell -3.24% 11.15%
CUTR Cutera, Inc. Sell -3.95% 0%
ATEC Alphatec Holdings, Inc. Sell -3.95% 0%
NKTR Nektar Therapeutics Sell -3.95% 0%
The percentage of cash held in the portfolio is: 100.98%
New Assets Added
  • CUTR
  • ATEC
  • NKTR
Assets Removed
None
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.25% 8.55%
MGNX MacroGenics, Inc. Buy 6.25% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.3% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 6.75% 0%
SEM Select Medical Holdings Corporation Sell -3.89% -3.34%
PACB Pacific Biosciences of California, Inc. Sell -4.13% -9.66%
IBRX ImmunityBio, Inc. Sell -3.61% 1.39%
FATE Fate Therapeutics, Inc. Sell -3.67% 0%
The percentage of cash held in the portfolio is: 89.77%
New Assets Added
  • FATE
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.99% 3.98%
MGNX MacroGenics, Inc. Buy 6.08% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.23% -0.46%
FATE Fate Therapeutics, Inc. Buy 6.26% 0%
SEM Select Medical Holdings Corporation Sell -3.91% -3.73%
PACB Pacific Biosciences of California, Inc. Sell -4.09% -8.52%
IBRX ImmunityBio, Inc. Sell -3.67% 0%
The percentage of cash held in the portfolio is: 87.1%
New Assets Added
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.99% 4.63%
MGNX MacroGenics, Inc. Buy 6.13% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.23% 0%
FATE Fate Therapeutics, Inc. Buy 6.23% 0%
SEM Select Medical Holdings Corporation Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 82.93%
New Assets Added
  • SEM
  • PACB
  • ARWR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0%
MGNX MacroGenics, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 88.47%
New Assets Added
  • APLS
  • MGNX
Assets Removed
Asset Action Perf %
OSUR Buy All 7.49%
Assets Rebalanced
None
2024-11-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
OSUR OraSure Technologies, Inc. Sell -3.59% 5.07%
The percentage of cash held in the portfolio is: 103.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
GERN Buy All 0.49%
TECH Buy All 0.4%
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
GERN Geron Corporation Sell -3.92% 1.21%
TECH Bio-Techne Corporation Sell -3.78% 4.57%
OSUR OraSure Technologies, Inc. Sell -3.53% 6.28%
The percentage of cash held in the portfolio is: 111.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Buy All 15.63%
KIDS Buy All -2.41%
ITGR Sell All 0.99%
Assets Rebalanced
None
2024-11-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 18.17% -0.64%
KIDS OrthoPediatrics Corp. Sell -4.4% -2.92%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.6% 15.9%
GERN Geron Corporation Sell -3.88% 2.43%
TECH Bio-Techne Corporation Sell -3.78% 4.87%
OSUR OraSure Technologies, Inc. Sell -3.51% 7%
The percentage of cash held in the portfolio is: 101%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMPH Buy All 3.34%
CHRS Sell All 34.15%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 7.5% 34.15%
ITGR Integer Holdings Corporation Buy 17.81% -2.48%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.86% 4.34%
KIDS OrthoPediatrics Corp. Sell -4.24% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.51% 17.98%
GERN Geron Corporation Sell -3.84% 3.16%
TECH Bio-Techne Corporation Sell -3.65% 7.99%
OSUR OraSure Technologies, Inc. Sell -3.47% 7.97%
The percentage of cash held in the portfolio is: 97.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Buy All 1.47%
HUM Sell All 1.89%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 9.71% -3.72%
CHRS Coherus BioSciences, Inc. Buy 5.7% 0.18%
ITGR Integer Holdings Corporation Buy 18.15% -2.37%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.88% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -3.96% 8.92%
KIDS OrthoPediatrics Corp. Sell -4.11% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.7% 14.91%
GERN Geron Corporation Sell -3.71% 8.01%
TECH Bio-Techne Corporation Sell -3.59% 11.14%
OSUR OraSure Technologies, Inc. Sell -3.58% 6.76%
The percentage of cash held in the portfolio is: 92.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 9.5% -5.95%
CHRS Coherus BioSciences, Inc. Buy 5.43% -4.76%
ITGR Integer Holdings Corporation Buy 18.3% -1.63%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.65% -4.98%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.93% 4.19%
TNDM Tandem Diabetes Care, Inc. Sell -4.09% 6.01%
KIDS OrthoPediatrics Corp. Sell -3.86% 11.31%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.76% 13.55%
GERN Geron Corporation Sell -3.71% 8.25%
TECH Bio-Techne Corporation Sell -3.62% 10.48%
OSUR OraSure Technologies, Inc. Sell -3.48% 9.42%
The percentage of cash held in the portfolio is: 86.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All 48.21%
IRTC Sell All -5.62%
CORT Sell All 5.11%
AVNS Sell All -8.39%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRTC iRhythm Technologies, Inc. Buy 7.21% -1.22%
CORT Corcept Therapeutics Incorporated Buy 6.49% 3.54%
AVNS Avanos Medical, Inc. Buy 5.29% -5.56%
HUM Humana Inc. Buy 9.65% -4.45%
CHRS Coherus BioSciences, Inc. Buy 5.17% -9.27%
ITGR Integer Holdings Corporation Buy 18.12% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.63% -5.24%
CUTR Cutera, Inc. Sell -2.38% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.98% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -3.89% 10.65%
KIDS OrthoPediatrics Corp. Sell -3.88% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.75% 13.91%
GERN Geron Corporation Sell -3.59% 11.17%
TECH Bio-Techne Corporation Sell -3.66% 9.53%
OSUR OraSure Technologies, Inc. Sell -3.57% 7%
The percentage of cash held in the portfolio is: 70.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
TGTX Sell All -3.9%
MGNX Sell All -7.75%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 5.86% -1.55%
IRTC iRhythm Technologies, Inc. Buy 7.32% 2.46%
CORT Corcept Therapeutics Incorporated Buy 6.72% 9.45%
AVNS Avanos Medical, Inc. Buy 5.31% -3.19%
HUM Humana Inc. Buy 9.7% -1.86%
CHRS Coherus BioSciences, Inc. Buy 5.26% -5.73%
ITGR Integer Holdings Corporation Buy 17.96% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.59% -3.91%
TGTX TG Therapeutics, Inc. Buy 6.88% 0.34%
RGEN Repligen Corporation Buy 6.62% -5.34%
CUTR Cutera, Inc. Sell -2.4% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.93% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -3.98% 6.57%
KIDS OrthoPediatrics Corp. Sell -3.76% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.9% 8.49%
GERN Geron Corporation Sell -3.56% 9.95%
TECH Bio-Techne Corporation Sell -3.84% 2.88%
OSUR OraSure Technologies, Inc. Sell -3.63% 3.62%
The percentage of cash held in the portfolio is: 50.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Sell All -1.68%
ATEC Sell All 11.21%
SAGE Sell All -15.03%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORMP Oramed Pharmaceuticals Inc. Buy 7.19% -2.52%
ATEC Alphatec Holdings, Inc. Buy 7.13% 16.31%
MGNX MacroGenics, Inc. Buy 5.62% -2.58%
IRTC iRhythm Technologies, Inc. Buy 7.41% 6.99%
CORT Corcept Therapeutics Incorporated Buy 6.72% 12.76%
AVNS Avanos Medical, Inc. Buy 5.24% -1.47%
HUM Humana Inc. Buy 9.62% 0.32%
SAGE Sage Therapeutics, Inc. Buy 4.91% -9.34%
CHRS Coherus BioSciences, Inc. Buy 5.14% -5%
ITGR Integer Holdings Corporation Buy 17.77% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.59% -0.89%
TGTX TG Therapeutics, Inc. Buy 7.54% 13.53%
ALT Altimmune, Inc. Buy 9.29% 0.32%
RGEN Repligen Corporation Buy 6.78% 0%
CUTR Cutera, Inc. Sell -2.54% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.85% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -4.01% 3.04%
KIDS OrthoPediatrics Corp. Sell -3.9% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.89% 5.78%
GERN Geron Corporation Sell -3.6% 6.07%
TECH Bio-Techne Corporation Sell -3.9% -1.66%
OSUR OraSure Technologies, Inc. Sell -3.57% 2.17%
The percentage of cash held in the portfolio is: 22.33%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
INCY Sell All 8.86%
ESPR Sell All -11.51%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
INCY Incyte Corporation Buy 6.9% 8.99%
ORMP Oramed Pharmaceuticals Inc. Buy 7.25% -1.68%
ATEC Alphatec Holdings, Inc. Buy 7.25% 18.22%
MGNX MacroGenics, Inc. Buy 6.11% 5.94%
IRTC iRhythm Technologies, Inc. Buy 7.42% 7.07%
CORT Corcept Therapeutics Incorporated Buy 6.87% 15.44%
AVNS Avanos Medical, Inc. Buy 5.35% 0.61%
HUM Humana Inc. Buy 9.31% -2.93%
CARA Cara Therapeutics, Inc. Buy 5.35% -1.16%
SAGE Sage Therapeutics, Inc. Buy 4.91% -9.34%
CHRS Coherus BioSciences, Inc. Buy 5.44% 0.49%
ITGR Integer Holdings Corporation Buy 17.68% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.56% -1.24%
ESPR Esperion Therapeutics, Inc. Buy 6.41% -3.57%
TGTX TG Therapeutics, Inc. Buy 6.68% 0.55%
ALT Altimmune, Inc. Buy 9.26% 0%
CUTR Cutera, Inc. Sell -2.75% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.04% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -4.2% -1.63%
KIDS OrthoPediatrics Corp. Sell -3.86% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.98% 3.7%
GERN Geron Corporation Sell -3.7% 3.64%
TECH Bio-Techne Corporation Sell -3.82% 0.37%
OSUR OraSure Technologies, Inc. Sell -3.65% 0%
The percentage of cash held in the portfolio is: 11.26%
New Assets Added
  • OSUR
  • ALT
Assets Removed
Asset Action Perf %
AVXL Sell All 36.25%
NEOG Sell All 6.97%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 7.11% 14.37%
INCY Incyte Corporation Buy 6.82% 10.28%
ORMP Oramed Pharmaceuticals Inc. Buy 7.03% -2.52%
ATEC Alphatec Holdings, Inc. Buy 7.41% 23.57%
AVXL Anavex Life Sciences Corp. Buy 7.96% 38.22%
MGNX MacroGenics, Inc. Buy 6.4% 13.44%
IRTC iRhythm Technologies, Inc. Buy 7.4% 9.2%
CORT Corcept Therapeutics Incorporated Buy 6.87% 17.98%
AVNS Avanos Medical, Inc. Buy 5.44% 4.6%
HUM Humana Inc. Buy 9.18% -2.1%
CARA Cara Therapeutics, Inc. Buy 5.23% -1.16%
SAGE Sage Therapeutics, Inc. Buy 5.27% -0.32%
CHRS Coherus BioSciences, Inc. Buy 5.03% -5%
ITGR Integer Holdings Corporation Buy 17.62% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.5% 0%
ESPR Esperion Therapeutics, Inc. Buy 6.5% 0%
TGTX TG Therapeutics, Inc. Buy 6.5% 0%
CUTR Cutera, Inc. Sell -2.69% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.02% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -4.14% -2.52%
KIDS OrthoPediatrics Corp. Sell -3.93% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.97% 1.81%
GERN Geron Corporation Sell -3.75% 0%
TECH Bio-Techne Corporation Sell -3.75% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • GERN
  • TECH
  • MDRX
  • ESPR
  • TGTX
Assets Removed
Asset Action Perf %
VERU Buy All 14.29%
DGX Buy All -2.73%
HCSG Sell All 11.51%
IOVA Sell All -3.45%
MCRB Sell All -15.61%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 6.8% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 5.93% -3.99%
NEOG Neogen Corporation Buy 7.07% 13.18%
INCY Incyte Corporation Buy 7.01% 12.78%
ORMP Oramed Pharmaceuticals Inc. Buy 7.03% -2.94%
MCRB Seres Therapeutics, Inc. Buy 6.32% -12.8%
ATEC Alphatec Holdings, Inc. Buy 7.21% 19.75%
AVXL Anavex Life Sciences Corp. Buy 8.07% 39.58%
MGNX MacroGenics, Inc. Buy 6.36% 12.4%
IRTC iRhythm Technologies, Inc. Buy 7.22% 6.19%
CORT Corcept Therapeutics Incorporated Buy 6.96% 19.06%
AVNS Avanos Medical, Inc. Buy 5.39% 3.19%
HUM Humana Inc. Buy 9.4% -0.14%
CARA Cara Therapeutics, Inc. Buy 5.24% -1.45%
SAGE Sage Therapeutics, Inc. Buy 5.3% -0.16%
CHRS Coherus BioSciences, Inc. Buy 5.28% -0.61%
ITGR Integer Holdings Corporation Buy 17.35% 0%
VERU Veru Inc. Sell -3.24% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.81% -2.21%
CUTR Cutera, Inc. Sell -2.7% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.01% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -4.06% 0%
KIDS OrthoPediatrics Corp. Sell -4.06% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.06% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
IART Sell All -0.52%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 6.81% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 6.96% 11.33%
NEOG Neogen Corporation Buy 6.95% 10.04%
INCY Incyte Corporation Buy 7% 11.38%
ORMP Oramed Pharmaceuticals Inc. Buy 7.33% 0%
MCRB Seres Therapeutics, Inc. Buy 6.39% -12.8%
ATEC Alphatec Holdings, Inc. Buy 7.3% 19.87%
AVXL Anavex Life Sciences Corp. Buy 6.75% 15.33%
MGNX MacroGenics, Inc. Buy 6.6% 15.25%
IRTC iRhythm Technologies, Inc. Buy 7.5% 8.99%
CORT Corcept Therapeutics Incorporated Buy 6.42% 8.47%
IART Integra LifeSciences Holdings Corporation Buy 5.41% 2.41%
AVNS Avanos Medical, Inc. Buy 5.46% 3.29%
HUM Humana Inc. Buy 9.5% -0.26%
CARA Cara Therapeutics, Inc. Buy 5.38% 0%
SAGE Sage Therapeutics, Inc. Buy 5.38% 0%
CHRS Coherus BioSciences, Inc. Buy 5.38% 0%
VERU Veru Inc. Sell -3.28% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.78% -0.18%
CUTR Cutera, Inc. Sell -3.58% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.87% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
  • SAGE
  • CHRS
Assets Removed
Asset Action Perf %
CHRS Buy All -13.57%
COLL Buy All -1.17%
NVRO Sell All -1.11%
QDEL Sell All -0.61%
IBRX Sell All 25.89%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 6.83% 28.74%
HCSG Healthcare Services Group, Inc. Buy 6.83% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 6.83% 10.06%
NEOG Neogen Corporation Buy 6.83% 8.93%
NVRO Nevro Corp. Buy 6.83% 7.04%
INCY Incyte Corporation Buy 6.83% 9.5%
ORMP Oramed Pharmaceuticals Inc. Buy 7.15% -1.68%
MCRB Seres Therapeutics, Inc. Buy 6.7% -7.93%
ATEC Alphatec Holdings, Inc. Buy 6.83% 12.99%
AVXL Anavex Life Sciences Corp. Buy 6.83% 17.67%
MGNX MacroGenics, Inc. Buy 6.16% 8.27%
IRTC iRhythm Technologies, Inc. Buy 7.51% 9.9%
QDEL QuidelOrtho Corporation Buy 6.99% 2.23%
CORT Corcept Therapeutics Incorporated Buy 6.36% 8.33%
IART Integra LifeSciences Holdings Corporation Buy 5.62% 7.19%
AVNS Avanos Medical, Inc. Buy 5.56% 5.92%
HUM Humana Inc. Buy 9.46% 0%
COLL Collegium Pharmaceutical, Inc. Sell -3.36% -0.55%
CHRS Coherus BioSciences, Inc. Sell -3.76% -0.28%
VERU Veru Inc. Sell -3.3% 11.9%
DGX Quest Diagnostics Incorporated Sell -3.73% 0.47%
CUTR Cutera, Inc. Sell -4.04% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HUM
Assets Removed
Asset Action Perf %
ALGN Buy All -6.63%
SMTI Buy All -11.47%
NVCR Buy All -19.24%
CDMO Sell All 5.98%
Assets Rebalanced
Asset Action Weight
CORT Sell -1.04%
MGNX Sell -1.71%
IBRX Sell -1.06%
NVRO Sell -1.19%
INCY Sell -1.38%
ATEC Sell -1.39%
NEOG Sell -1.57%
AVXL Sell -1.73%
HCSG Sell -2.15%
IOVA Sell -2.28%
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 5.43% 1.74%
IBRX ImmunityBio, Inc. Buy 8.17% 29.22%
HCSG Healthcare Services Group, Inc. Buy 8.89% 4.02%
IOVA Iovance Biotherapeutics, Inc. Buy 9.03% 5.71%
NEOG Neogen Corporation Buy 8.34% 4.74%
NVRO Nevro Corp. Buy 7.97% 2.96%
INCY Incyte Corporation Buy 8.09% 4.53%
ATEC Alphatec Holdings, Inc. Buy 8.21% 9.3%
AVXL Anavex Life Sciences Corp. Buy 8.73% 16.31%
MCRB Seres Therapeutics, Inc. Buy 7.44% -0.98%
ORMP Oramed Pharmaceuticals Inc. Buy 7.41% -1.26%
MGNX MacroGenics, Inc. Buy 7.3% -2.58%
IRTC iRhythm Technologies, Inc. Buy 7.51% 6.43%
CORT Corcept Therapeutics Incorporated Buy 7.35% 4.16%
QDEL QuidelOrtho Corporation Buy 7.13% 1.13%
IART Integra LifeSciences Holdings Corporation Buy 5.41% 0%
AVNS Avanos Medical, Inc. Buy 5.41% 0%
SMTI Sanara MedTech Inc. Sell -3.69% -6.97%
COLL Collegium Pharmaceutical, Inc. Sell -3.36% 2.59%
CHRS Coherus BioSciences, Inc. Sell -3.91% -1.25%
VERU Veru Inc. Sell -3.4% 11.9%
DGX Quest Diagnostics Incorporated Sell -3.82% 1.17%
ALGN Align Technology, Inc. Sell -3.58% -0.61%
NVCR NovoCure Limited Sell -3.83% -9.49%
CUTR Cutera, Inc. Sell -4.24% -5.36%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IART
  • AVNS
Assets Removed
Asset Action Perf %
NUTX Sell All 0.73%
PTCT Sell All 3.94%
Assets Rebalanced
None
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 5.09% -7.17%
PTCT PTC Therapeutics, Inc. Buy 5.63% 2.72%
CDMO Avid Bioservices, Inc. Buy 5.49% -0.19%
IBRX ImmunityBio, Inc. Buy 8.05% 23.52%
HCSG Healthcare Services Group, Inc. Buy 8.98% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 9.13% 3.72%
NEOG Neogen Corporation Buy 8.25% 0.63%
NVRO Nevro Corp. Buy 7.9% -0.93%
INCY Incyte Corporation Buy 8.17% 2.46%
ATEC Alphatec Holdings, Inc. Buy 8.24% 6.5%
AVXL Anavex Life Sciences Corp. Buy 8.53% 10.27%
MCRB Seres Therapeutics, Inc. Buy 7.61% -1.59%
ORMP Oramed Pharmaceuticals Inc. Buy 7.77% 0.42%
MGNX MacroGenics, Inc. Buy 7.38% -4.39%
IRTC iRhythm Technologies, Inc. Buy 7.26% 0%
CORT Corcept Therapeutics Incorporated Buy 7.26% 0%
QDEL QuidelOrtho Corporation Buy 7.26% 0%
SMTI Sanara MedTech Inc. Sell -3.77% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -3.39% 4.63%
CHRS Coherus BioSciences, Inc. Sell -3.69% 7.2%
VERU Veru Inc. Sell -3.46% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.94% 1.02%
ALGN Align Technology, Inc. Sell -3.66% 0.04%
NVCR NovoCure Limited Sell -3.94% -9.29%
CUTR Cutera, Inc. Sell -4.14% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
  • IRTC
  • CORT
  • QDEL
Assets Removed
Asset Action Perf %
EVH Buy All -0.73%
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.99% -8.94%
PTCT PTC Therapeutics, Inc. Buy 5.64% 2.92%
CDMO Avid Bioservices, Inc. Buy 5.45% -0.87%
VKTX Viking Therapeutics, Inc. Buy 6.48% -0.46%
IBRX ImmunityBio, Inc. Buy 8.17% 25.42%
HCSG Healthcare Services Group, Inc. Buy 8.96% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 8.93% 1.45%
NEOG Neogen Corporation Buy 8.26% 0.7%
NVRO Nevro Corp. Buy 8.16% 2.41%
INCY Incyte Corporation Buy 8.21% 2.98%
ATEC Alphatec Holdings, Inc. Buy 7.99% 3.31%
AVXL Anavex Life Sciences Corp. Buy 7.99% 3.25%
MCRB Seres Therapeutics, Inc. Buy 7.75% 0.24%
ORMP Oramed Pharmaceuticals Inc. Buy 7.54% -2.52%
MGNX MacroGenics, Inc. Buy 7.72% 0%
EVH Evolent Health, Inc. Sell -3.43% -1.16%
SMTI Sanara MedTech Inc. Sell -3.78% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -3.47% 2.48%
CHRS Coherus BioSciences, Inc. Sell -3.99% -0.14%
VERU Veru Inc. Sell -3.6% 9.52%
DGX Quest Diagnostics Incorporated Sell -3.96% 0.4%
ALGN Align Technology, Inc. Sell -3.63% 1.08%
NVCR NovoCure Limited Sell -3.84% -6.59%
The percentage of cash held in the portfolio is: 17.45%
New Assets Added
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 5% -10.19%
PTCT PTC Therapeutics, Inc. Buy 5.66% 1.53%
CDMO Avid Bioservices, Inc. Buy 5.38% -3.86%
VKTX Viking Therapeutics, Inc. Buy 6.56% -0.93%
IBRX ImmunityBio, Inc. Buy 8.2% 23.75%
HCSG Healthcare Services Group, Inc. Buy 8.97% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 8.47% -5.35%
NEOG Neogen Corporation Buy 8.31% -0.42%
NVRO Nevro Corp. Buy 8.27% 2.04%
INCY Incyte Corporation Buy 8.13% 0.26%
ATEC Alphatec Holdings, Inc. Buy 7.87% 0%
AVXL Anavex Life Sciences Corp. Buy 7.87% 0%
MCRB Seres Therapeutics, Inc. Buy 7.87% 0%
ORMP Oramed Pharmaceuticals Inc. Buy 7.87% 0%
EVH Evolent Health, Inc. Sell -3.47% -0.69%
SMTI Sanara MedTech Inc. Sell -3.78% -4.6%
COLL Collegium Pharmaceutical, Inc. Sell -3.6% 0.5%
CHRS Coherus BioSciences, Inc. Sell -4.18% -3.19%
VERU Veru Inc. Sell -3.66% 9.52%
DGX Quest Diagnostics Incorporated Sell -4.02% 0.7%
ALGN Align Technology, Inc. Sell -3.63% 2.76%
NVCR NovoCure Limited Sell -3.66% 0%
The percentage of cash held in the portfolio is: 25.6%
New Assets Added
  • NVCR
  • ATEC
  • AVXL
  • MCRB
  • ORMP
Assets Removed
Asset Action Perf %
VREX Sell All 8.51%
AXSM Sell All -4.63%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.78% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 5.02% -4.17%
NUTX Nutex Health Inc. Buy 5.21% -5.16%
PTCT PTC Therapeutics, Inc. Buy 5.68% 3.41%
CDMO Avid Bioservices, Inc. Buy 5.4% -2.03%
VKTX Viking Therapeutics, Inc. Buy 6.4% -2.01%
IBRX ImmunityBio, Inc. Buy 8.75% 33.97%
HCSG Healthcare Services Group, Inc. Buy 8.91% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 8.84% 0.09%
NEOG Neogen Corporation Buy 8.36% 1.6%
NVRO Nevro Corp. Buy 7.99% 0%
INCY Incyte Corporation Buy 7.99% 0%
EVH Evolent Health, Inc. Sell -3.54% -4.1%
SMTI Sanara MedTech Inc. Sell -3.7% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -3.6% -1.05%
CHRS Coherus BioSciences, Inc. Sell -4.15% -3.88%
VERU Veru Inc. Sell -3.66% 8.33%
DGX Quest Diagnostics Incorporated Sell -3.99% -0.01%
ALGN Align Technology, Inc. Sell -3.68% 0%
The percentage of cash held in the portfolio is: 41.97%
New Assets Added
  • ALGN
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
BHVN Buy All 1.96%
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.78% 10%
AXSM Axsome Therapeutics, Inc. Buy 5.08% -3.21%
NUTX Nutex Health Inc. Buy 4.9% -10.96%
PTCT PTC Therapeutics, Inc. Buy 5.95% 8.09%
CDMO Avid Bioservices, Inc. Buy 5.43% -1.74%
ALGN Align Technology, Inc. Buy 6.44% -1.68%
VKTX Viking Therapeutics, Inc. Buy 6.56% 0.18%
IBRX ImmunityBio, Inc. Buy 8.73% 33.25%
HCSG Healthcare Services Group, Inc. Buy 8.9% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 8.67% -1.99%
NEOG Neogen Corporation Buy 8.25% 0%
BHVN Biohaven Ltd. Sell -3.48% 1.01%
EVH Evolent Health, Inc. Sell -3.42% -0.34%
SMTI Sanara MedTech Inc. Sell -3.67% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -3.67% -2.71%
CHRS Coherus BioSciences, Inc. Sell -4.12% -2.91%
VERU Veru Inc. Sell -3.81% 4.76%
DGX Quest Diagnostics Incorporated Sell -4% -0.03%
The percentage of cash held in the portfolio is: 51.47%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.64% 8.68%
NKTR Nektar Therapeutics Buy 4.86% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 5.01% -3.47%
NUTX Nutex Health Inc. Buy 5.26% -3.3%
PTCT PTC Therapeutics, Inc. Buy 5.6% 2.95%
CDMO Avid Bioservices, Inc. Buy 5.32% -2.51%
ALGN Align Technology, Inc. Buy 6.45% -0.29%
VKTX Viking Therapeutics, Inc. Buy 6.58% 1.78%
IBRX ImmunityBio, Inc. Buy 9.47% 46.56%
HCSG Healthcare Services Group, Inc. Buy 8.73% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 8.73% 0%
BHVN Biohaven Ltd. Sell -3.49% -0.54%
EVH Evolent Health, Inc. Sell -3.43% -1.81%
SMTI Sanara MedTech Inc. Sell -3.67% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -3.61% -2.39%
CHRS Coherus BioSciences, Inc. Sell -3.95% 0%
VERU Veru Inc. Sell -3.95% 0%
DGX Quest Diagnostics Incorporated Sell -3.95% 0%
The percentage of cash held in the portfolio is: 54.4%
New Assets Added
  • CHRS
  • VERU
  • DGX
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
ARWR Sell All 4.24%
VCEL Sell All 8.48%
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.8% 3.82%
VCEL Vericel Corporation Buy 6.8% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 10.12% 54.64%
VREX Varex Imaging Corporation Buy 5.81% 6.69%
NKTR Nektar Therapeutics Buy 4.96% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 5.25% -3.73%
NUTX Nutex Health Inc. Buy 5.59% -2.14%
PTCT PTC Therapeutics, Inc. Buy 5.92% 3.64%
CDMO Avid Bioservices, Inc. Buy 5.53% -3.47%
ALGN Align Technology, Inc. Buy 6.88% 1.33%
VKTX Viking Therapeutics, Inc. Buy 7.24% 6.57%
IBRX ImmunityBio, Inc. Buy 8.58% 26.37%
BHVN Biohaven Ltd. Sell -3.74% -2.66%
EVH Evolent Health, Inc. Sell -3.66% -3.58%
SMTI Sanara MedTech Inc. Sell -3.73% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.75% -1.14%
The percentage of cash held in the portfolio is: 35.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARDX Sell All -4.47%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.47% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.87% 2.94%
VCEL Vericel Corporation Buy 6.8% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 10.25% 53.61%
VREX Varex Imaging Corporation Buy 5.89% 5.95%
NKTR Nektar Therapeutics Buy 5.17% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 5.29% -4.84%
NUTX Nutex Health Inc. Buy 5.77% -0.97%
PTCT PTC Therapeutics, Inc. Buy 6.13% 5.29%
CDMO Avid Bioservices, Inc. Buy 5.76% -1.45%
ALGN Align Technology, Inc. Buy 6.93% 0%
VKTX Viking Therapeutics, Inc. Buy 6.93% 0%
IBRX ImmunityBio, Inc. Buy 6.93% 0%
BHVN Biohaven Ltd. Sell -3.78% -1.73%
EVH Evolent Health, Inc. Sell -3.54% 1.81%
SMTI Sanara MedTech Inc. Sell -3.78% 0%
COLL Collegium Pharmaceutical, Inc. Sell -3.78% 0%
The percentage of cash held in the portfolio is: 29.7%
New Assets Added
  • SMTI
  • COLL
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.14% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.84% 2.89%
VCEL Vericel Corporation Buy 6.68% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 10.55% 58.76%
VREX Varex Imaging Corporation Buy 5.83% 5.37%
NKTR Nektar Therapeutics Buy 5.38% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 5.47% -1.1%
NUTX Nutex Health Inc. Buy 5.52% -4.88%
PTCT PTC Therapeutics, Inc. Buy 6.27% 8.04%
CDMO Avid Bioservices, Inc. Buy 5.82% 0%
BHVN Biohaven Ltd. Sell -3.79% -2.49%
EVH Evolent Health, Inc. Sell -3.47% 3.41%
The percentage of cash held in the portfolio is: 42.76%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.47% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.12% 5.27%
VCEL Vericel Corporation Buy 6.72% -0.62%
CDXS Codexis, Inc. Buy 6.58% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 8.44% 24.74%
VREX Varex Imaging Corporation Buy 5.84% 3.64%
NKTR Nektar Therapeutics Buy 5.59% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 5.57% -1.02%
NUTX Nutex Health Inc. Buy 5.9% 0%
PTCT PTC Therapeutics, Inc. Buy 5.9% 0%
BHVN Biohaven Ltd. Sell -3.85% -2.29%
EVH Evolent Health, Inc. Sell -3.62% 0.99%
The percentage of cash held in the portfolio is: 43.33%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.73% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.32% 5.84%
VCEL Vericel Corporation Buy 6.77% -2.16%
CDXS Codexis, Inc. Buy 6.71% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 6.49% -6.19%
VREX Varex Imaging Corporation Buy 6% 4.13%
NKTR Nektar Therapeutics Buy 5.52% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.59% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 5.64% -1.98%
BHVN Biohaven Ltd. Sell -3.84% 0.25%
EVH Evolent Health, Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 50.82%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.6% -3.31%
BKD Brookdale Senior Living Inc. Buy 7.43% 8.76%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.47% 9.4%
VCEL Vericel Corporation Buy 6.76% -1.02%
CDXS Codexis, Inc. Buy 6.87% 0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.48% -5.08%
VREX Varex Imaging Corporation Buy 5.8% 2.07%
NKTR Nektar Therapeutics Buy 5.53% -2.76%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.88% 3.48%
AXSM Axsome Therapeutics, Inc. Buy 5.69% 0%
BHVN Biohaven Ltd. Sell -3.91% -2.89%
The percentage of cash held in the portfolio is: 39.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRTC Buy All 0.06%
ORGO Sell All 2.6%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.62% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.5% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.63% -3.37%
CDXS Codexis, Inc. Buy 6.82% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.65% -3.09%
VREX Varex Imaging Corporation Buy 5.71% 0%
NKTR Nektar Therapeutics Buy 5.71% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.71% 0%
AXSM Axsome Therapeutics, Inc. Buy 5.71% 0%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.35%
BHVN Biohaven Ltd. Sell -3.83% -0.33%
The percentage of cash held in the portfolio is: 36.27%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 7.14% 5.52%
ARDX Ardelyx, Inc. Buy 6.53% -3.15%
BKD Brookdale Senior Living Inc. Buy 7.44% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.35% 8.99%
VCEL Vericel Corporation Buy 6.61% -1.95%
RDNT RadNet, Inc. Buy 6.72% -0.34%
CDXS Codexis, Inc. Buy 7% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 6.89% 2.27%
IRTC iRhythm Technologies, Inc. Sell -3.64% 1.5%
AXSM Axsome Therapeutics, Inc. Sell -3.84% -3.9%
BHVN Biohaven Ltd. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 55.55%
New Assets Added
  • BHVN
Assets Removed
Asset Action Perf %
ORMP Buy All -1.67%
CUTR Buy All 9.25%
FATE Buy All 0%
IRWD Sell All 5.63%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.57% 3.05%
ORGO Organogenesis Holdings Inc. Buy 7.1% 3.9%
ARDX Ardelyx, Inc. Buy 6.73% -1.16%
BKD Brookdale Senior Living Inc. Buy 6.83% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.99% 2.69%
VCEL Vericel Corporation Buy 6.79% -0.33%
RDNT RadNet, Inc. Buy 6.82% 0.2%
CDXS Codexis, Inc. Buy 6.81% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.81% 0%
CUTR Cutera, Inc. Sell -3.42% 8%
FATE Fate Therapeutics, Inc. Sell -3.53% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.66% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.58% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -3.73% 0.18%
The percentage of cash held in the portfolio is: 56.47%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.45% 0.7%
ORGO Organogenesis Holdings Inc. Buy 6.9% 0.32%
ARDX Ardelyx, Inc. Buy 6.79% -0.83%
BKD Brookdale Senior Living Inc. Buy 6.85% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.85% 0%
VCEL Vericel Corporation Buy 6.85% 0%
RDNT RadNet, Inc. Buy 6.85% 0%
CUTR Cutera, Inc. Sell -3.54% 5.33%
FATE Fate Therapeutics, Inc. Sell -3.55% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.72% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.47% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -3.7% 1.35%
The percentage of cash held in the portfolio is: 70.46%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
ORGO Organogenesis Holdings Inc. Buy 6.88% -0.32%
ARDX Ardelyx, Inc. Buy 6.87% 0%
CUTR Cutera, Inc. Sell -3.8% -1.33%
FATE Fate Therapeutics, Inc. Sell -3.61% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -3.74% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.43% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -3.81% -1.12%
The percentage of cash held in the portfolio is: 98.21%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.34% -1.17%
ORGO Organogenesis Holdings Inc. Buy 6.75% -1.95%
CUTR Cutera, Inc. Sell -3.64% 2.67%
FATE Fate Therapeutics, Inc. Sell -3.43% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -3.76% -0.42%
IRTC iRhythm Technologies, Inc. Sell -3.44% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -3.61% 4.05%
The percentage of cash held in the portfolio is: 104.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.48% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.89% 0%
ORGO Organogenesis Holdings Inc. Buy 6.89% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -3.68% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.76% 0%
AXSM Axsome Therapeutics, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 98.45%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.75% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 104.82%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All 2.48%
Assets Rebalanced
None
2024-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
MYGN Myriad Genetics, Inc. Buy 7.19% 4.89%
The percentage of cash held in the portfolio is: 92.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -1.16%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 6.7% -2.44%
MYGN Myriad Genetics, Inc. Buy 7.24% 5.56%
The percentage of cash held in the portfolio is: 86.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Buy All 15.64%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 6.87% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.14% 3.45%
CERS Cerus Corporation Sell -3.87% 2.37%
The percentage of cash held in the portfolio is: 89.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 9.65% 40.42%
NVCR NovoCure Limited Buy 7.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 7.09% 2.3%
CERS Cerus Corporation Sell -3.9% 1.9%
The percentage of cash held in the portfolio is: 80.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All 5.41%
ESPR Sell All 4.37%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 9.47% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.01% 27.5%
NVCR NovoCure Limited Buy 6.8% -4.54%
MYGN Myriad Genetics, Inc. Buy 6.94% -2.56%
CERS Cerus Corporation Sell -3.97% 2.84%
The percentage of cash held in the portfolio is: 63.02%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
LMAT Buy All 2.57%
AVXL Buy All 12.76%
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.63% 10.8%
MGNX MacroGenics, Inc. Buy 9.28% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.65% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.42% 33.75%
NVCR NovoCure Limited Buy 6.65% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.11% 0.26%
LMAT LeMaitre Vascular, Inc. Sell -3.69% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.24% 14.88%
VREX Varex Imaging Corporation Sell -3.95% 2.99%
CERS Cerus Corporation Sell -3.96% 2.84%
The percentage of cash held in the portfolio is: 64.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 6.89%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.36% 7.2%
MGNX MacroGenics, Inc. Buy 9.04% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.54% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.48% 33.96%
NVCR NovoCure Limited Buy 6.56% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.17% 0.63%
STAA STAAR Surgical Company Sell -3.6% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.35% 12.41%
VREX Varex Imaging Corporation Sell -3.58% 12.56%
CERS Cerus Corporation Sell -3.92% 4.27%
The percentage of cash held in the portfolio is: 68.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
SGMO Buy All -22.22%
ALDX Sell All -6.49%
AADI Sell All 3.43%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.65% 4.57%
PODD Insulet Corporation Buy 9.33% 5.05%
MGNX MacroGenics, Inc. Buy 8.66% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.43% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.23% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.42% -3.01%
NVCR NovoCure Limited Buy 6.78% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.25% 0%
STAA STAAR Surgical Company Sell -3.79% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.84% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.4% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
SGMO Sangamo Therapeutics, Inc. Sell -3.04% 0%
The percentage of cash held in the portfolio is: 67.25%
New Assets Added
  • SGMO
  • MYGN
Assets Removed
Asset Action Perf %
CDMO Buy All 16.54%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.35% 5.72%
MGNX MacroGenics, Inc. Buy 8.96% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.41% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 7.61% 0%
NVCR NovoCure Limited Buy 7.22% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.79% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.66% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.09% 1.42%
The percentage of cash held in the portfolio is: 74.41%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
CARA Sell All -6.41%
AGEN Sell All -8.59%
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 7.59% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 70.33%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
APLS Sell All -5.21%
ORGO Sell All -4.59%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings